Drug General Information
Drug ID
D05BTR
Former ID
DNC001408
Drug Name
Tallimustine
Drug Type
Small molecular drug
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Discontinued in Phase 2 [544837]
Structure
Download
2D MOL

3D MOL

Formula
C32H38Cl2N10O4
Canonical SMILES
CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NCC<br />C(=N)N)C)C)NC(=O)C4=CC=C(C=C4)N(CCCl)CCCl
InChI
1S/C32H38Cl2N10O4/c1-41-18-22(14-25(41)30(46)37-11-8-28(35)36)39-32(48)27-16-23(19-43(27)3)40-31(47)26-15-21(17-42(26)2)38-29(45)20-4-6-24(7-5-20)44(12-9-33)13-10-34/h4-7,14-19H,8-13H2,1-3H3,(H3,35,36)(H,37,46)(H,38,45)(H,39,48)(H,40,47)
InChIKey
ARKYUICTMUZVEW-UHFFFAOYSA-N
CAS Number
CAS 138112-76-2
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Human DNA Target Info Modulator
References
Ref 544837Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001279)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.